Bifidobacterium breve is a mixture of Maltodextrin with probiotics powder, it can be used to make capsule or sachet directly. B. breve strains were originally isolated from the feces of human infants. In 1971, Bifidobacterium parvulorum and Bifidobacterium breve were merged under the name Bifidobacterium breve. Bifidobacterim breve administered in combination with prebiotics or other probiotics and standard therapy has showed some beneficial effect. B. breve is a constituent in the therapeutic, nutritional treatment VSL#3. This proprietary, standardized, formulation of live bacteria is used to treat ulcerative colitis and requires a prescription.
- Gut-flora balance
- Helps fight intestinal tract illnesses, like IBS, IBD
- Protection against pathogens
- Assists in prevention of urinary tract infections
- Helps to build a superior immune system
- Anti-allergy
- Assists in the absorption of nutrients
- Suppresses occurrences of eczema
- Decreases antibiotic side effects
- Aids in dairy product digestion among the lactose-intolerant
- Decreases duration of diarrhea
-
Medication, HealthCare, Dietary Supplements, in forms of capsules, tablet, sachets/strips, drops etc.
- Food applicated products, juices, gummies, chocolate, candies, bakeries etc.
- Dairy products, like yoghurts etc.
- Pets foods/Animal feed additives etc
| Analysis | Description | Test Method |
| Appearance | Milk white to yellowish powder, no rancid caking, no peculiar smell, no smell | Dryer |
| Ash | ≤7.0% | Dryer |
| The total number of living bacteria | ≥1.0×1010cfu/g | CP2010 |
| Coliform | n=5,c=2,m=10,m=102 | CP2010 |